Literature DB >> 32245525

Pathophysiology of Hepatic Encephalopathy.

Ariel Jaffe1, Joseph K Lim2, Sofia Simona Jakab3.   

Abstract

Hepatic encephalopathy (HE) is one of the major clinical decompensations of cirrhosis, with a high impact on health care resource utilization and cost. For an effective and comprehensive management of HE, the clinicians need to understand the pathophysiologic mechanisms of HE. This review describes the multiorgan processes involved in HE and how several HE precipitants and treatment strategies act on ammonia production, excretion, and neurotoxicity, including the impact of diabetes and use of cannabinoids. The authors also discuss the current and future role of gut microbiome, systemic/central inflammation, and various neurotransmitters for the pathogenesis and treatment of HE. Published by Elsevier Inc.

Entities:  

Keywords:  Ammonia; Cannabinoids; Gut-liver-brain axis; Hepatic encephalopathy; Liver cirrhosis; Neurotoxicity; Neurotransmitters; TNF-Alpha

Mesh:

Substances:

Year:  2020        PMID: 32245525     DOI: 10.1016/j.cld.2020.01.002

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  3 in total

1.  Development and Validation of Prognostic Models to Estimate the Risk of Overt Hepatic Encephalopathy After TIPS Creation: A Multicenter Study.

Authors:  Chongtu Yang; Xiaoli Zhu; Jiacheng Liu; Qin Shi; Hang Du; Yang Chen; Songjiang Huang; Chen Zhou; Yingliang Wang; Tongqiang Li; Yaowei Bai; Bin Xiong
Journal:  Clin Transl Gastroenterol       Date:  2022-01-27       Impact factor: 4.396

2.  Risk Factor Analysis of Hepatic Encephalopathy and the Establishment of Diagnostic Model.

Authors:  Fangfang Chen; Jing Li; Wenjie Zhang; Caixia Mao; Yanxia Wang; Yan Qu; Shuju Tian; Fanhong Li
Journal:  Biomed Res Int       Date:  2022-07-19       Impact factor: 3.246

Review 3.  Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective.

Authors:  Jiachen Liu; Yantao Xu; Bimei Jiang
Journal:  Front Cell Infect Microbiol       Date:  2021-02-22       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.